Researchers led by ETH Zurich Professor Berend Snijder have discovered a chemical that, at least in vitro, successfully combats glioblastomas: vortioxetine, an antidepressant. Scientists understand ...

ETH Zurich researchers discover the potential of antidepressants in treating aggressive brain tumors like glioblastoma.

Artificial muscles are powering a new robot leg developed by researchers at ETH Zurich and the Max Planck Institute for Intelligent Systems.

Anumula Jithendar Reddy, our today's IIT-JEE success story subject is the perfect embodiment of this sentiment, having topped ...

People with glioblastomas - a deadly brain tumour with no current cure - face just a five per cent chance of surviving beyond ...

Antidepressant vortioxetine shows potential in treating brain tumors, offering new hope in cancer therapy by targeting tumor ...

As Storm Boris brought devastating floods to central and eastern Europe, skeptics on social media dismissed the role of ...

While clay is widely used to build basic structures such as huts, we typically don't see it being utilized in large-scale ...

A CHEAP drug that’s already on the market could be effective against deadly brain tumours, scientists say. Glioblastomas are ...

Research in cell cultures and mice demonstrates an antidepressant called vortioxetine may be effective in combating glioblastomas.

Researchers have now found a substance that effectively combats glioblastomas, at least in the laboratory: an antidepressant ...

Vortioxetine, an antidepressant, shows promise against glioblastoma in lab tests conducted by ETH Zurich, leading to ...